Angiogenesis in cancer and other diseases - PubMed (original) (raw)
Review
. 2000 Sep 14;407(6801):249-57.
doi: 10.1038/35025220.
Affiliations
- PMID: 11001068
- DOI: 10.1038/35025220
Review
Angiogenesis in cancer and other diseases
P Carmeliet et al. Nature. 2000.
Abstract
Pathological angiogenesis is a hallmark of cancer and various ischaemic and inflammatory diseases. Concentrated efforts in this area of research are leading to the discovery of a growing number of pro- and anti-angiogenic molecules, some of which are already in clinical trials. The complex interactions among these molecules and how they affect vascular structure and function in different environments are now beginning to be elucidated. This integrated understanding is leading to the development of a number of exciting and bold approaches to treat cancer and other diseases. But owing to several unanswered questions, caution is needed.
Similar articles
- [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
Plouet J. Plouet J. Ann Pathol. 1999;19(5 Suppl):S70-1. Ann Pathol. 1999. PMID: 10599456 French. No abstract available. - Vascular endothelial growth factor as a target for antiangiogenic therapy.
Gordon MS. Gordon MS. J Clin Oncol. 2000 Nov 1;18(21 Suppl):45S-6S. J Clin Oncol. 2000. PMID: 11060326 No abstract available. - Angiogenesis-dependent diseases and angiogenesis therapy.
Tímár J, Döme B, Fazekas K, Janovics A, Paku S. Tímár J, et al. Pathol Oncol Res. 2001;7(2):85-94. doi: 10.1007/BF03032573. Pathol Oncol Res. 2001. PMID: 11458270 Review. - Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.
Shinkaruk S, Bayle M, Laïn G, Déléris G. Shinkaruk S, et al. Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. doi: 10.2174/1568011033353452. Curr Med Chem Anticancer Agents. 2003. PMID: 12678905 Review.
Cited by
- Efficacy of Atezolizumab Plus Bevacizumab-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
Moriyama E, Shimose S, Niizeki T, Iwamoto H, Tanaka M, Shirono T, Noda Y, Nakano M, Kuromatsu R, Koga H, Kawaguchi T. Moriyama E, et al. Curr Oncol. 2024 Sep 27;31(10):5821-5831. doi: 10.3390/curroncol31100432. Curr Oncol. 2024. PMID: 39451736 Free PMC article. - The recent progress of the mechanism and regulation of tumor necrosis in colorectal cancer.
Zhang X, Chen L. Zhang X, et al. J Cancer Res Clin Oncol. 2016 Feb;142(2):453-63. doi: 10.1007/s00432-015-1997-z. Epub 2015 Jun 21. J Cancer Res Clin Oncol. 2016. PMID: 26094047 Review. - The dual roles of homeobox genes in vascularization and wound healing.
Kachgal S, Mace KA, Boudreau NJ. Kachgal S, et al. Cell Adh Migr. 2012 Nov-Dec;6(6):457-70. doi: 10.4161/cam.22164. Epub 2012 Oct 17. Cell Adh Migr. 2012. PMID: 23076135 Free PMC article. Review. - The Association of Suppressed Hypoxia-Inducible Factor-1 Transactivation of Angiogenesis With Defective Recovery From Cerebral Ischemic Injury in Aged Rats.
Guo Y, Zhou J, Li X, Xiao Y, Zhang J, Yang Y, Feng L, Kang YJ. Guo Y, et al. Front Aging Neurosci. 2021 Feb 26;13:648115. doi: 10.3389/fnagi.2021.648115. eCollection 2021. Front Aging Neurosci. 2021. PMID: 33716719 Free PMC article. - Adrenomedullin Up-regulates the Expression of Vascular Endothelial Growth Factor in Epithelial Ovarian Carcinoma Cells via JNK/AP-1 Pathway.
Chen Q, Chen P, Pang X, Hu Y, Zhang Y. Chen Q, et al. Int J Gynecol Cancer. 2015 Jul;25(6):953-60. doi: 10.1097/IGC.0000000000000465. Int J Gynecol Cancer. 2015. PMID: 26098087 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources